Robert Tepper

Dr. Robert I.
Tepper, MD, is a Partner at Third Rock Ventures GP LP, a Partner at Third Rock Ventures LLC, a Chairman at Kibur Medical, Inc., a Council Member of National Center for Advancing Translational Sciences and a Member-Overseers Board at Tufts University.
He is on the Board of Directors at The Possible Project, Inc. Dr. Tepper was previously employed as an Independent Director by Neon Therapeutics, Inc., an Independent Director by Allena Pharmaceuticals, Inc., an Independent Director by bluebird bio, Inc., an Independent Director by Kala Pharmaceuticals, Inc., an Independent Director by Constellation Pharmaceuticals, Inc., an Independent Director by Cerulean Pharma, Inc., a President-Research & Development by Takeda Oncology Co., a Co-Founder by Abgenix, Inc., a Founder by Cell Genesys, Inc., an Independent Director by Jounce Therapeutics, Inc., and a Principal Investigator by The Massachusetts General Hospital.
He also served on the board at Alnara Pharmaceuticals, Inc., Alcresta Therapeutics, Inc., Casma Therapeutics, Inc., Faze Medicines, Inc. /MA) and Foundation Medicine, Inc. He received his undergraduate degree from Princeton University and a doctorate degree from Harvard Medical School.